Ultrahuman has raised $70 million, including $65 million of primary equity and $5 million of debt. Among the named participants, Alteria Capital is the only typical debt provider, so the debt sleeve is assumed to sit with Alteria, though that is not stated explicitly.
Mohit Kumar, Founder and Chief Executive of Ultrahuman, told TechCrunch the round comprises $65 million in primary equity and $5 million in debt. Qualcomm Ventures participated alongside Labcorp, Alpha Wave, Blume Ventures, Nexus Venture Partners and Alteria Capital.
Ultrahuman, the Bengaluru wearables and health-tech company co-founded in 2019 by Kumar and Vatsal Singhal, plans to use the capital to deepen its presence in markets including India and the UAE, expand clinical research and fund product development.
Ultrahuman began with continuous glucose monitors but smart rings are now its mainstay, alongside blood testing and environmental sensing. The company has sold about 800,000 rings and is at an annual revenue run rate of about $140 million, up roughly 45 per cent year on year, and expects that run rate to reach $200 million by January 2027. The US accounts for about 45 per cent of revenue this quarter, with India contributing about 11 per cent, and about 12 per cent of users pay for Ultrahuman's PowerPlugs subscription software.
The $5 million debt component follows ₹100 crore of venture debt Alteria provided Ultrahuman in November 2025. Ultrahuman raised a $35 million Series B mix in March 2024, comprising about $25 million of equity and $10 million of debt, from investors including Blume Ventures, Steadview Capital, Nexus Venture Partners, Alpha Wave and Deepinder Goyal.
Alteria Capital, an India venture debt firm, says it has funded more than $750 million across more than 200 portfolio companies and manages $550 million of assets.